Skip to main content

1 Result(s)

within Mark Thalgott Remove this filter Surgical Oncology Remove this filter

and

  1. Article

    Open Access

    Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

    Circulating tumor cell (CTCs) counts might serve as early surrogate marker for treatment efficacy in metastatic castration-resistant prostate cancer (mCRPC) patients. We prospectively assessed categorical and ...

    Mark Thalgott, Brigitte Rack, Matthias Eiber, Michael Souvatzoglou… in BMC Cancer (2015)

    Download PDF (771 KB) View Article